Meeting Posters

Development of a digital health tool evaluation framework for operational sponsor considerations in clinical trials (Abstract)

DeBonis
2024 Autumn Conference

Artefact rejection in EEG and quality control (Abstract)

Das
2024 Autumn Conference

Two for the price of one: HAM-D rating variability does not necessarily increase with the number of raters (Abstract)

Cole
2024 Autumn Conference

Capturing changes in positive affect and social functioning using ecological momentary assessment (EMA) in a 12-month treatment trial in schizophrenia (Abstract)

Chaturvedi
2024 Autumn Conference

Assessing amnestic mild cognitive impairment using smartphone-based ecological momentary cognitive testing: Sensitivity of various performance metrics (Abstract)

Campbell
2024 Autumn Conference

Patient ratings from a genetic biomarker guided trial with liafensine support clinician-rated findings in patients with treatment resistant depression (Abstract)

Alphs
2024 Autumn Conference

Measurement of positive and negative symptoms through speech analysis from PANSS interview recordings in patients with schizophrenia (Abstract)

Abbas
2024 Autumn Conference

Investigating cognitive practice effects in schizophrenia using repeated assessment at short retest intervals (Abstract)

Wacker
20th Annual Scientific Meeting

Measuring clinically relevant change in apathy symptoms in ADMET & ADMET2 (Abstract)

Tumati
20th Annual Scientific Meeting

Word of the day: Patient perspectives in a Phase 4 open-label study of adjunctive brexpiprazole in MDD (Abstract)

Therrien
20th Annual Scientific Meeting

Use of a novel pharmacogenomic biomarker to enrich responders for liafensine in TRD (Abstract)

Spear
20th Annual Scientific Meeting

A pilot trial of symptom-triggered alcohol withdrawal management delivered over telemedicine (Abstract)

Sloan
20th Annual Scientific Meeting

Clinical Outcome Assessments in clinical trials: When is the gold standard just the old standard (Abstract)

Skirrow
20th Annual Scientific Meeting

Are trial endpoints actually on point? Longitudinal measurement invariance in depression trials using MADRS (Abstract)

Sirbu
20th Annual Scientific Meeting

Towards multimodal dysarthria assessment that incorporates clinical judgement (Abstract)

Simmatis
20th Annual Scientific Meeting

Estimating heterogeneity of treatment effects in clinical trials (Abstract)

Siegel
20th Annual Scientific Meeting

Different last 4 of ID provided – A red flag for the professional subject? (Abstract)

Shiovitz
20th Annual Scientific Meeting

Quantitative standardized brain network activity measures to inform CNS treatment development (Abstract)

Setton
20th Annual Scientific Meeting

Precision matters: Analysis of how various scores behave measuring change over time (Abstract)

Psimas
20th Annual Scientific Meeting

Understanding the challenges of masking in psychedelic clinical trials: A comprehensive review (Abstract)

Price
20th Annual Scientific Meeting